NKGNW
NKGen Biotech, Inc. Warrants
NASDAQ · Healthcare · Biotechnology · US
$0.03
+2408.33%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.02x
- Price / sales
- 1.33x
- Price / cash flow
- -0.04x
Enterprise value
- Enterprise value
- $39.1M
- EV / sales
- 59.90x
- EV / EBITDA
- -5.79x
- EV / EBIT
- -1.63x
- Market cap
- $867.8K
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2025